Tamar S. Polonsky to Middle Aged
This is a "connection" page, showing publications Tamar S. Polonsky has written about Middle Aged.
Connection Strength
0.725
-
Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 Apr; 79(4):893-903.
Score: 0.063
-
Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.
Score: 0.053
-
Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York. JAMA Cardiol. 2017 06 01; 2(6):627-634.
Score: 0.040
-
Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Mar 20; 6(3).
Score: 0.040
-
Exercise Treadmill Testing. JAMA. 2015 Nov 10; 314(18):1968-9.
Score: 0.036
-
High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 2014 Nov; 237(1):169-76.
Score: 0.033
-
Coronary artery calcium score. JAMA. 2014 Aug 27; 312(8):837-8.
Score: 0.033
-
Coronary artery calcium testing: dos and don'ts. Cardiol Clin. 2012 Feb; 30(1):49-55.
Score: 0.027
-
The contribution of early nephropathy to cardiovascular risk. Cardiol Clin. 2010 Aug; 28(3):427-36.
Score: 0.025
-
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010 Apr 28; 303(16):1610-6.
Score: 0.025
-
The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009 Dec; 207(2):440-4.
Score: 0.023
-
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
Score: 0.016
-
Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. JAMA Netw Open. 2023 09 05; 6(9):e2334590.
Score: 0.015
-
Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial. J Am Heart Assoc. 2023 09 05; 12(17):e031182.
Score: 0.015
-
Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. JAMA. 2022 10 04; 328(13):1315-1325.
Score: 0.015
-
Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023 Feb; 77(2):506-514.
Score: 0.014
-
Urban Spatial Accessibility of Primary Care and Hypertension Control and Awareness on Chicago's South Side: A Study From the COMPASS Cohort. Circ Cardiovasc Qual Outcomes. 2022 09; 15(9):e008845.
Score: 0.014
-
NT-pro B-type natriuretic peptide, early menopause, and incident heart failure in postmenopausal women of the ARIC study. Menopause. 2022 01 14; 29(3):309-316.
Score: 0.014
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
Score: 0.013
-
Optimal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Reduces Daytime Resting Heart Rate in Prediabetes: A Randomized Controlled Study. J Am Heart Assoc. 2020 10 20; 9(19):e016871.
Score: 0.013
-
Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. J Vasc Surg. 2021 02; 73(2):608-625.
Score: 0.012
-
Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 2020 08; 25(4):319-327.
Score: 0.012
-
Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy. J Am Heart Assoc. 2020 04 07; 9(7):e015197.
Score: 0.012
-
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537.
Score: 0.011
-
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018 10 23; 138(17):e595-e616.
Score: 0.011
-
Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676.
Score: 0.011
-
Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. JAMA. 2017 12 05; 318(21):2089-2098.
Score: 0.010
-
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
Score: 0.010
-
Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017 09; 66(3):826-834.
Score: 0.010
-
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017 07; 102(1):106-114.
Score: 0.010
-
Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events. JACC Cardiovasc Imaging. 2017 09; 10(9):1003-1012.
Score: 0.010
-
Obesity and Cardiovascular Risk in Adults With Celiac Disease. J Clin Gastroenterol. 2016 08; 50(7):545-50.
Score: 0.009
-
European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry. Circulation. 2016 Jul 19; 134(3):201-11.
Score: 0.009
-
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016 Jan 19; 67(2):139-147.
Score: 0.009
-
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation. 2015 Sep 08; 132(10):916-22.
Score: 0.009
-
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012 Aug 22; 308(8):788-95.
Score: 0.007
-
Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials. 2012 Apr; 9(2):232-46.
Score: 0.007
-
Automated border detection for assessing the mechanical properties of the carotid arteries: comparison with carotid intima-media thickness. J Am Soc Echocardiogr. 2010 May; 23(5):567-72.
Score: 0.006
-
Diagnostic value of parametric imaging of left ventricular wall motion from contrast-enhanced echocardiograms in patients with poor acoustic windows. J Am Soc Echocardiogr. 2009 Mar; 22(3):276-83.
Score: 0.006
-
Use of carotid intima-media thickness to identify patients with ischemic stroke and transient ischemic attack with low yield of cardiovascular sources of embolus on transesophageal echocardiography. Stroke. 2008 Nov; 39(11):2969-74.
Score: 0.005
-
Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest. 2007 Apr; 131(4):964-71.
Score: 0.005
-
Quantification of regional left ventricular wall motion from real-time 3-dimensional echocardiography in patients with poor acoustic windows: effects of contrast enhancement tested against cardiac magnetic resonance. J Am Soc Echocardiogr. 2006 Jul; 19(7):886-93.
Score: 0.005